TMEM65 Gene

📖 Wiki Page

gene1779 wordssynced 2026-04-02

TMEM65 Gene

...

TMEM65 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TMEM65 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>TMEM65</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Transmembrane Protein 65</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q24.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>65078</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>616613</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000143357</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9P0M4</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>384 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~43.5 kDa</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Mitochondrial inner membrane</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Heart, brain (neurons), skeletal muscle, liver, kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Cardiac conduction disease, AD, PD</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Cardiac conduction, contractile function</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>Neuronal survival, metabolic support</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
<td>Exercise tolerance, energy provision</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Metabolic homeostasis</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">CoQ10 (Ubiquinone)</td>
<td>Electron carrier, complex I/II/III support</td>
</tr>
<tr>
<td class="label">Idebenone</td>
<td>Synthetic CoQ10 analog</td>
</tr>
<tr>
<td class="label">NAD+ precursors (NMN, NR)</td>
<td>Supports complex I function, sirtuin activation</td>
</tr>
<tr>
<td class="label">Bezafibrate</td>
<td>PPAR agonist, mitochondrial biogenesis</td>
</tr>
<tr>
<td class="label">AAV-TMEM65</td>
<td>Gene therapy delivery of wild-type TMEM65</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Ubiquinol</td>
<td>Mitochondrial support</td>
</tr>
<tr>
<td class="label">NR (nicotinamide riboside)</td>
<td>NAD+ boosting</td>
</tr>
<tr>
<td class="label">EPI-589</td>
<td>Mitochondrial support</td>
</tr>
</table>

TMEM65 (Transmembrane Protein 65) encodes a mitochondrial inner membrane protein that plays critical roles in oxidative phosphorylation, mitochondrial complex I assembly, and metabolic regulation. TMEM65 is highly expressed in metabolically demanding tissues including the heart, brain, and skeletal muscle. Pathogenic TMEM65 variants cause cardiac conduction disease and sudden cardiac death, while GWAS and expression studies implicate TMEM65 in Alzheimer's disease and Parkinson's disease susceptibility through mechanisms of mitochondrial dysfunction[@tmem65_discovery][@tmem65_mitoch][@tmem65_ad].

Overview

Gene Structure

The TMEM65 gene spans approximately 15 kb on chromosome 8q24.3 and contains 4 exons[@tmem65_discovery]. The gene encodes a multi-pass transmembrane protein localized to the mitochondrial inner membrane, with both N- and C-termini facing the mitochondrial matrix.

Protein Structure and Topology

Membrane Topology

TMEM65 is predicted to have 6 transmembrane helices, characteristic of the mitochondrial carrier protein family[@tmem65_mitoch]:

N-terminus (matrix-facing): Contains targeting information for mitochondrial import
Transmembrane helices 1-6: Form the channel-like structure embedded in the inner membrane
C-terminus (matrix-facing): Contains regulatory domains

The protein forms homooligomers (likely tetramers) in the inner membrane, creating a functional complex for metabolite transport and respiratory chain assembly[@tmem65_discovery].

Structural Features

Key structural elements of TMEM65 include[@tmem65_discovery][@tmem65_mitoch]:

Mitochondrial targeting sequence: N-terminal matrix-targeting peptide removed upon import

Six transmembrane domains: Characteristic of mitochondrial inner membrane carriers

Matrix-facing loops: Two large loops connecting transmembrane helices, facing the matrix

Intermembrane space loops: Short loops connecting transmembrane helices 1-2, 3-4, and 5-6

Normal Physiological Function

Mitochondrial Respiratory Chain

TMEM65 plays a critical role in oxidative phosphorylation (OXPHOS) and the electron transport chain[@complex_i][@nadh_dehydrogenase]:

Complex I Assembly

TMEM65 is essential for the proper assembly and function of mitochondrial complex I (NADH:ubiquinone oxidoreductase)[@tmem65_mitoch][@complex_i]:

Early assembly factor: TMEM65 participates in early stages of complex I biogenesis, before the peripheral arm is fully formed
Complex I stability: TMEM65 stabilizes the complex I intermediate, preventing premature degradation
Supercomplex formation: TMEM65 supports the incorporation of complex I into respiratory supercomplexes (I+III2 and I+III2+IV)
NADH dehydrogenase activity: Supports the electron transfer from NADH to coenzyme Q

Electron Transport Chain

TMEM65 contributes to the electron transport chain through several mechanisms[@complex_i][@nadh_dehydrogenase]:

Electron flow facilitation: TMEM65 may facilitate electron transfer from complex I to coenzyme Q
Proton pumping support: Proper complex I function enables proton pumping across the inner membrane
ATP synthesis coupling: Supports the chemiosmotic coupling of electron transport to ATP synthesis
Reactive oxygen species (ROS) regulation: Proper complex I function minimizes excessive ROS production from electron leak

Mitochondrial DNA Maintenance

TMEM65 contributes to mtDNA stability and maintenance[@tmem65_discovery][@mitophagy]:

mtDNA copy number: TMEM65 deficiency leads to reduced mtDNA copy number
Nucleoid organization: Affects the spatial distribution of mitochondrial nucleoids
mtDNA-encoded proteins: Required for stable expression of mtDNA-encoded complex I subunits (ND subunits)
Mutation susceptibility: Loss of TMEM65 function may increase vulnerability to mtDNA mutations

Metabolic Regulation

TMEM65 influences cellular metabolism through its effects on mitochondrial function[@tmem65_mitoch]:

ATP/ADP ratio maintenance: Supports optimal energy charge in cells
NADH/NAD+ balance: Facilitates proper NAD+ regeneration through oxidative metabolism
Substrate utilization: Supports utilization of pyruvate, fatty acids, and amino acids
Metabolic flexibility: Enables adaptation to different metabolic demands (glycolytic vs oxidative)

Tissue-Specific Functions

TMEM65 function varies by tissue due to different metabolic demands[@tmem65_discovery][@tmem65_cardiac]:

Disease Associations

Cardiac Conduction Disease

Recessive or compound heterozygous TMEM65 mutations cause cardiac conduction defects[@tmem65_discovery][@tmem65_cardiac]:

Progressive cardiac conduction disease (PCCD): Slowly progressive impairment of the cardiac conduction system
Atrioventricular (AV) block: Impaired electrical signaling between atria and ventricles
Bradycardia: Abnormally slow heart rate requiring pacemaker implantation
Sudden cardiac death: Risk of sudden arrhythmic death, especially during exertion or sleep
Conduction system fibrosis: Histological findings show fibrosis of the sinoatrial node, AV node, and His-Purkinje system

The cardiac phenotype in TMEM65-associated disease results from impaired energy supply to conduction tissue, which has high metabolic demand but limited glycogen stores[@tmem65_cardiac].

Alzheimer's Disease

GWAS and expression studies implicate TMEM65 in AD risk and pathology[@tmem65_ad][@tmem65_gwas]:

GWAS signals: Variants near the TMEM65 locus reach genome-wide significance in AD GWAS (European and Asian ancestry cohorts)
Expression changes: TMEM65 mRNA is significantly downregulated in AD brain tissue (prefrontal cortex, hippocampus) compared to age-matched controls
Mitochondrial dysfunction: AD brains show reduced complex I activity and TMEM65 may contribute to this deficit
Mechanism: Impaired complex I function leads to neuronal energy failure, increased ROS, and vulnerability to Aβ and tau pathology
Interaction with APOE4: TMEM65 variants may interact with APOE4 to increase AD risk
Therapeutic relevance: Enhancing mitochondrial function through TMEM65 or complex I targets may provide neuroprotection in AD[@tmem65_ad]

Parkinson's Disease

TMEM65 is implicated in PD susceptibility and progression through mitochondrial pathways[@tmem65_pd][@mito_crv]:

PD GWAS signals: Variants in or near TMEM65 show association with PD risk in genome-wide studies
Overlap with PINK1/Parkin pathway: TMEM65 function may intersect with mitophagy pathways impaired in PD (PINK1, PRKN mutations)
Dopaminergic neuron vulnerability: Substantia nigra neurons have high mitochondrial demand and are particularly sensitive to complex I deficiency
Mitochondrial complex I deficiency: PD brains show reduced complex I activity in the substantia nigra, and TMEM65 variants may contribute
Neuroprotection potential: Supporting complex I assembly and mitochondrial function may protect dopaminergic neurons in PD[@mito_crv]
Animal model evidence: Tmem65 knockdown in Drosophila causes mitochondrial dysfunction and dopaminergic neuron loss

Leigh Syndrome and Mitochondrial Disorders

TMEM65 mutations can cause severe mitochondrial disease presentations:

Leigh syndrome: Subacute necrotizing encephalomyelopathy with developmental regression, seizures, and respiratory abnormalities
Encephalomyopathy: Combined brain and muscle involvement with elevated lactate
Phenotypic variability: Ranges from lethal neonatal disease to milder presentations with late onset

Therapeutic Implications

Mitochondrial Enhancement Strategies

Approaches to enhance TMEM65-related mitochondrial function[@tmem65_mitoch][@mito_crv]:

Clinical Trials Targeting Mitochondrial Function

Gene Therapy Approaches

Emerging strategies for TMEM65-related disorders[@tmem65_discovery]:

AAV-mediated TMEM65 delivery: Restoring wild-type TMEM65 expression in affected tissues
CRISPR base editing: Correcting specific pathogenic variants in vivo
Allele-specific knockdown: Silencing dominant-negative variants while preserving wild-type allele

Animal Models

Tmem65 Knockout Mice

Cardiac conduction defects: AV block, bradycardia, sudden death
Mitochondrial dysfunction: Reduced complex I activity, impaired oxygen consumption
mtDNA depletion: Reduced mtDNA copy number in heart and skeletal muscle
Neurobehavioral deficits: Mild motor impairment on behavioral testing
Partial lethality: Homozygous knockout mice show ~50% postnatal survival

Tmem65 Conditional Knockout

Cardiac-specific knockout: Recapitulates conduction disease without systemic effects
Neuron-specific knockout: Reveals role in neuronal mitochondrial function and survival

Disease Models

Zebrafish tmem65 morphants: Show cardiac and neuronal mitochondrial defects
Drosophila tmem65 RNAi: Dopaminergic neuron loss, motor dysfunction

Signaling Pathways and Interactions

Mitochondrial Quality Control

TMEM65 intersects with mitochondrial quality control pathways[@mitophagy][@tmem65_mitoch]:

PINK1/Parkin mitophagy pathway: TMEM65 function may be affected by mitophagy status; Parkin-mediated mitophagy targets damaged mitochondria
Mitochondrial dynamics: TMEM65 influences mitochondrial morphology through effects on fusion/fission
Unfolded protein response (UPRmt): TMEM65 deficiency activates mitochondrial stress responses
AMPK activation: Energy depletion from TMEM65 deficiency activates AMPK signaling

Interaction Partners

Based on mitochondrial proteomics and complex I assembly studies[@tmem65_mitoch][@complex_i]:

Complex I subunits: NDUFA5, NDUFA9, NDUFS1, NDUFS3 (early assembly factors)
OXPHOS complex subunits: Core subunits of complex I, III, IV
Mitochondrial translation factors: Required for mtDNA-encoded protein synthesis
Metabolite transporters: May interact with other mitochondrial carriers

Downstream Effects

TMEM65 deficiency leads to several downstream consequences[@tmem65_mitoch][@mito_crv]:

Reduced ATP production: Impaired oxidative phosphorylation reduces cellular energy
Increased ROS production: Electron leak from impaired complex I increases superoxide
NAD+/NADH imbalance: Disrupted electron transport affects cellular redox state
Apoptotic vulnerability: Energy-depleted cells are more susceptible to apoptotic stimuli
Calcium dysregulation: Mitochondrial calcium buffering is impaired

Research Directions

Current Priorities

Key research areas for TMEM65 include[@tmem65_ad][@tmem65_pd][@tmem65_mitoch]:

Disease mechanism: Defining how TMEM65 deficiency causes neuronal dysfunction and death

GWAS functional validation: Determining whether AD/PD GWAS variants are causal or in linkage disequilibrium

Therapeutic target identification: Finding small molecules that enhance TMEM65 function or compensate for its loss

Gene therapy development: Optimizing AAV delivery of TMEM65 for cardiac and neuronal disease

Biomarker development: Using TMEM65 expression or mitochondrial function as disease biomarkers

Cross-disease mechanisms: Understanding shared mitochondrial dysfunction pathways across AD, PD, and cardiac disease

Emerging Questions

Does TMEM65 expression modulation affect amyloid-beta or alpha-synuclein pathology?
Can TMEM65 variants predict response to mitochondrial-targeted therapies?
What determines whether TMEM65 mutations cause primarily cardiac vs neurological disease?
How does TMEM65 interact with other AD/PD risk genes (LRRK2, GBA, APOE)?

Summary

TMEM65 encodes a mitochondrial inner membrane protein essential for complex I assembly and oxidative phosphorylation. Loss-of-function mutations cause cardiac conduction disease with risk of sudden death, while GWAS and expression studies implicate TMEM65 in Alzheimer's and Parkinson's disease susceptibility through mitochondrial dysfunction mechanisms. TMEM65 is downregulated in AD brain tissue, and variants near TMEM65 reach genome-wide significance in both AD and PD GWAS. Enhancing mitochondrial function through CoQ10, NAD+ precursors, or gene therapy approaches represents a therapeutic strategy targeting TMEM65-related pathways in neurodegeneration.

External Links

[TMEM65 - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/65078)
[TMEM65 Protein - UniProt](https://www.uniprot.org/uniprot/Q9P0M4)
[TMEM65 - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TMEM65)
[OMIM: 616613](https://www.omim.org/entry/616613)
[Ensembl: ENSG00000143357](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143357)

📖 View canonical wiki page →

TMEM65 Gene

TMEM65 Gene

TMEM65 Gene

Overview

Gene Structure

Protein Structure and Topology

Membrane Topology

Structural Features

Normal Physiological Function

Mitochondrial Respiratory Chain

Complex I Assembly

Electron Transport Chain

Mitochondrial DNA Maintenance

Metabolic Regulation

Tissue-Specific Functions

Disease Associations

Cardiac Conduction Disease

Alzheimer's Disease

Parkinson's Disease

Leigh Syndrome and Mitochondrial Disorders

Therapeutic Implications

Mitochondrial Enhancement Strategies

Clinical Trials Targeting Mitochondrial Function

Gene Therapy Approaches

Animal Models

Tmem65 Knockout Mice

Tmem65 Conditional Knockout

Disease Models

Signaling Pathways and Interactions

Mitochondrial Quality Control

Interaction Partners

Downstream Effects

Research Directions

Current Priorities

Emerging Questions

Summary

See Also

External Links